Covered recipient · General Payments record
PAULETTE S NANKIVEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$4,772.64
- Reported across 235 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $628.60 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $182.43 | 3 |
| Amgen Inc. | $180.79 | 6 |
| Lilly USA, LLC | $103.80 | 6 |
| ABBVIE INC. | $51.55 | 3 |
| Exact Sciences Corporation | $30.79 | 2 |
| E.R. Squibb & Sons, L.L.C. | $30.65 | 2 |
| Merck Sharp & Dohme Corporation | $17.95 | 1 |
| Daiichi Sankyo Inc. | $17.44 | 1 |
| Novo Nordisk AS | $13.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.51 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107718990 | CMS |
| ABBVIE INC. | $19.82 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107718992 | CMS |
| ABBVIE INC. | $14.22 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107718994 | CMS |
| Amgen Inc. | $7.94 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336636 | CMS |
| Amgen Inc. | $7.98 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336638 | CMS |
| Amgen Inc. | $19.36 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336640 | CMS |
| Amgen Inc. | $11.40 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336642 | CMS |
| Amgen Inc. | $9.11 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117336644 | CMS |
| Amgen Inc. | $125.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117638113 | CMS |
| AstraZeneca Pharmaceuticals LP | $43.49 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104483724 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.31 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105509220 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.63 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105850962 | CMS |
| Daiichi Sankyo Inc. | $17.44 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089461603 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101541916 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.95 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101541995 | CMS |
| Exact Sciences Corporation | $17.08 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114555160 | CMS |
| Exact Sciences Corporation | $13.71 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114555164 | CMS |
| Lilly USA, LLC | $18.87 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920312 | CMS |
| Lilly USA, LLC | $14.47 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135912411 | CMS |
| Lilly USA, LLC | $16.36 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920314 | CMS |
| Lilly USA, LLC | $18.16 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135854235 | CMS |
| Lilly USA, LLC | $18.02 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135854231 | CMS |
| Lilly USA, LLC | $17.92 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135912413 | CMS |
| Merck Sharp & Dohme LLC | $17.95 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141915189 | CMS |
| Novo Nordisk Inc | $13.20 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100509131 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.